Well, this global challenge is not new. It does seem that it's happening more quickly. And that is that emerging viral threats tend to test our limits of capability to be able to respond locally as well as globally. And that continues to become perhaps an even greater challenge because as the world in essence gets smaller, we travel much more. We are seeing that emerging viral threats, in fact, emerging pathogenic threats are happening, it seems like more frequently, they migrate much faster and we have to figure out ways to be able to respond to those.

Sep 15, 2026 / receipt / David Dodd, CEO | earnings call 2026-09-15 | transcript 0fb8185c-0f15-4f6b-8072-949660b1e2dd | chars 3975-4534 | segment 3

And that will not simply stay in that location, that geography, it will travel. Because as people travel more and more, coming to the World Cup, coming to other types of travel, they will be carrying it. That's what we're seeing already with impact. And we've seen it previously with other parts of the Ebola family.

Sep 15, 2026 / receipt / David Dodd, CEO | earnings call 2026-09-15 | transcript 0fb8185c-0f15-4f6b-8072-949660b1e2dd | chars 10284-10600 | segment 10

In August and September 2025, we entered into new agreements for the lease of laboratory space and office space. Each of these agreements provided access to the respective spaces beginning November 1, 2025 for three -year original terms, with periodic base rent adjustments throughout the terms.

filing / May 14, 2026 / receipt

As of March 31, 2026, the remaining terms of our office lease and laboratory lease are 2.6 years and 0.5 years, respectively.

filing / May 14, 2026 / receipt